(Q39934783)

15 September 2017

High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients (English)

1 reference

15 September 2017

0 references

V N Patel

1

1 reference

15 September 2017

R G Mungwira

2

1 reference

15 September 2017

T F Tarumbiswa

3

1 reference

15 September 2017

T Heikinheimo

4

1 reference

15 September 2017

J J van Oosterhout

5

1 reference

15 September 2017

1 May 2010

1 reference

International Journal of STD & AIDS

15 September 2017

1 reference

15 September 2017

21

1 reference

15 September 2017

5

1 reference

15 September 2017

356-358

1 reference

Dementia and neurocognitive disorders due to HIV-1 infection

15 September 2017

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2010.009554

21 January 2018

Identifiers

DOI

10.1258/IJSA.2010.009554

1 reference

15 September 2017

1 reference